On an executive hiring spree, Sarepta snags Biogen's Gilmore O'Neill as new CMO
Sarepta has snagged ex-Biogen executive Gilmore O’Neill to join the leadership as CMO, filling the position just one year after its last CMO hire.
Last April, the company had brought in former Regeneron exec Catherine Stehman-Breen to serve as its chief medical officer, despite her inexperience with Duchenne drugs. At the time, then-CEO Ed Kaye pointed to her “extensive experience in global development, clinical operations and research across multiple therapeutic areas” as reasoning for her hire. But it appears Stehman-Breen quietly left Sarepta just 8 months later, although Sarepta never issued a press release regarding her departure.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.